- ►diabetesjournals.org HS Kahn, KM Curtis, PA Marchbanks - Diabetes care, 2003 - Am Diabetes Assoc Progestin-only contraceptives administered by injection (Depo-Provera) or subcutaneous implant
(Norplant) have been available to US women for about a decade. Two epidemiological studies
found their use associated with increased incidence of type 2 diabetes. In reviewing ... Cited by 22 - Related articles - BL Direct - All 6 versions
C Kim, KW Seidel, EA Begier, YS … - Archives of Internal …, 2001 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ... Cited by 20 - Related articles - BL Direct - All 9 versions
LJ Dorflinger - Contraception, 2002 - Elsevier The metabolic impact of progestin-only contraceptives is less than that of combined oral
contraceptives. Subdermal contraceptive implant systems that provide a sustained release of
low levels of progestins are now becoming widely available. This review evaluates the ... Cited by 39 - Related articles - BL Direct - All 12 versions
R Kimmerle, L Heinemann, M Berger - Diabetes Care, 1995 - popline.org Checkbox_Abstract. Your search found 1 record(s). New Basic Search | New
Advanced Search | POPLINE Document Delivery Policy 1. Title ... Cited by 5 - Related articles - Cached - All 5 versions
[CITATION] Oral contraception in women with diabetes
KR Petersen - Danish medical bulletin, 2002 - 万方数据资源系统 Even small increases in the frequency of thrombotic disease in users of OCs have general health
impact because of their widespread use, which is currently expanding to potential risk
groups. The present investigations were launched to study the effects of OCs containing ... Cited by 10 - Related articles - BL Direct - All 3 versions
FN Shamma, G Rossi, L HajHassan, AS Penzias, M … - Fertility and …, 1995 - ncbi.nlm.nih.gov OBJECTIVES: To assess the impact of a levonorgestrel-releasing implant contraceptive
(Norplant; Wyeth-Ayerst Laboratories, Philadelphia, PA) on glucose metabolism. DESIGN: Prospective
evaluation of insulin action and secretion in women under hyperglycemic ... Cited by 22 - Related articles - BL Direct - All 5 versions
S Graff-Iversen, S Tonstad - Contraception, 2002 - Elsevier This population-based cross-sectional study assessed lipid and lipoprotein parameters in women
using progestogen-only contraceptives or medications and in those using no hormones. Unselected
women about age 40 to 42 years were invited, and the participation rate was 65.6%. A ... Cited by 13 - Related articles - All 10 versions
[CITATION] Effects of growth hormone releasing hormone (GHRH) administration on the …
